You are here

  • Home
  • Archive
  • Volume 25, Issue 6
  • Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019800
Mar 20192000
Apr 20192200
May 20193000
Jun 20191200
Jul 20192900
Aug 20192201
Sep 20191800
Oct 20193800
Nov 20192800
Dec 20192600
Jan 20202800
Feb 20202201
Mar 20204101
Apr 20201900
May 20203600
Jun 20201202
Jul 20204200
Aug 20202000
Sep 20202400
Oct 20201400
Nov 2020900
Dec 2020900
Jan 20212100
Feb 20211601
Mar 20211200
Apr 2021800
May 2021800
Jun 2021100
Oct 20213600
Nov 20211200
Dec 20213700
Jan 20223800
Feb 20223100
Mar 20224400
Apr 20221800
May 20228500
Jun 20229801
Jul 20223600
Aug 20229303
Sep 20225801
Oct 20226000
Nov 20224000
Dec 20223800
Jan 20232801
Feb 20235400
Mar 20231200
Apr 20231200
May 20233000
Jun 20236500
Jul 20231600
Aug 20232300
Sep 20231100
Oct 20231800
Nov 20231600
Dec 20233600
Jan 20243600
Feb 20243601
Mar 20245400
Apr 20241800
Total1784013